NeoGenomics, Inc. (NASDAQ:NEO) | WebDisclosure

Basculer en Français

10965	Companies
240129	Keywords
168906	Articles
129229	Press releases

Home
Companies
NeoGenomics, Inc.

PRESS RELEASE

published on 12/28/2023 at 14:10, 2 years 8 months ago

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE

published on 12/05/2023 at 14:00, 2 years 9 months ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE

published on 11/14/2023 at 13:00, 2 years 9 months ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE

published on 11/06/2023 at 22:05, 2 years 10 months ago

NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE

published on 10/24/2023 at 13:00, 2 years 10 months ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE

published on 10/17/2023 at 15:20, 2 years 10 months ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Accesswire

Published on 09/11/2026 at 23:00, 1 hour 17 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 2 hours 12 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 52 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 7 hours 17 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 7 hours 17 minutes ago

Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 22:15, 2 hours 2 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 hours 7 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 4 hours 32 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 6 hours 2 minutes ago

CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:07, 6 hours 10 minutes ago

Holding(s) in Company

Les Echos

Published on 09/11/2026 at 07:00, 17 hours 17 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 17 hours 17 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 17 hours 17 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 17 hours 17 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 4 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE